| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 15,179 | 15,095 | 16,182 | 16,176 | | Cost of Revenue | 2,431 | 2,749 | 3,096 | 3,799 | | | Gross Profit |
-
| 12,346 | 13,086 | 12,377 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 10,248 | 9,943 | 9,428 | 8,638 | | Non Recurring |
-
|
-
|
-
| 1,185 | | Others | 9,424 | 719 | 624 | 17,243 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| 1,684 | 3,034 | (14,689) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | (6,924) | 1,684 | 3,034 | (14,689) | | Interest Expense | 758 | 880 | 960 | 1,316 | | Income Before Tax | (7,682) | 804 | 2,074 | (16,005) | | Income Tax Expense | (3,011) | 134 | 613 | (6,265) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (4,671) | 670 | 1,461 | (9,740) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (4,671) | 670 | 1,461 | (9,740) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($4,671) | $670 | $1,461 | ($9,740) |
|
0.31% Nasdaq 
0.05%
Income Statement
